| Range: | 0.61-4.04 | Vol Avg: | 2600500 | Last Div: | 0 | Changes: | 0.11 |
| Beta: | 0.51 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Fri Oct 29 2021 | Empoloyees: | 83 | ||
| CUSIP: | 09077D100 | CIK: | 0001858685 | ISIN: | US09077D2099 | Country: | US |
| CEO: | Dr. Hermann Luebbert Ph.D. | Website: | https://www.biofrontera.us.com | ||||
BFRI 0.98 Stock Price Biofrontera Inc.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Stock Details
Positive 0.45
Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note
WOBURN, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofron...
globenewswire.com·Fri Nov 22 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow